17β-tert-Butoxyestra-1,3,5(10)-trien-3-ol

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: 17β-tert-Butoxyestra-1,3,5(10)-trien-3-ol
• 英文别名: (8R,9S,13S,14S,17S)-13-methyl-17-[(2-methylpropan-2-yl)oxy]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-ol
• 化学式: C₂₂H₃₂O₂
• 分子量: 328.495
• InChiKey: IPBPKFLYXNVFFV-KOVVAJLHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  24
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.73
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  雌二醇 在 硫酸 、 lithium 作用下， 以 1,4-二氧六环 、 乙二醇二甲醚 为溶剂， 生成 17β-tert-Butoxyestra-1,3,5(10)-trien-3-ol
  参考文献：
  名称：

  Cherkasov,A.N. et al., Journal of Organic Chemistry USSR (English Translation), 1974, vol. 10, p. 321 - 328

  摘要：

  DOI：

文献信息

• Demethylpenclomedine Analogs and Their Use as Anti-Cancer Agents
  申请人：Morgan Lee Roy

  公开号：US20090197844A1

  公开（公告）日：2009-08-06

  This disclosure concerns novel demethylpenclomedine analogs. Also disclosed are pharmaceutical compositions and methods for using such compositions to treat hyperproliferative disorders. In one embodiment the analogs are represented by the formula

  本披露涉及新型去甲基喷托莫啉类似物。还披露了制备这种类似物的制药组合物和使用这种组合物治疗过度增殖性疾病的方法。在一种实施例中，这些类似物由以下公式表示：
• Demethylpenclomedine analogs and their use as anti-cancer agents
  申请人：Dekk-Tec, Inc.

  公开号：US10772878B2

  公开（公告）日：2020-09-15

  This disclosure concerns novel demethylpenclomedine analogs. Also disclosed are pharmaceutical compositions and methods for using such compositions to treat hyperproliferative disorders. In one embodiment the analogs are represented by the formula

  本公开涉及新型去甲斑蝥素类似物。还公开了药物组合物和使用此类组合物治疗过度增殖性疾病的方法。在一个实施方案中，类似物由式表示
• DEMETHYLPENCLOMEDINE ANALOGS AND THEIR USE AS ANTI-CANCER AGENTS
  申请人：Morgan Lee Roy

  公开号：US20120177634A1

  公开（公告）日：2012-07-12

  This disclosure concerns novel demethylpenclomedine analogs. Also disclosed are pharmaceutical compositions and methods for using such compositions to treat hyperproliferative disorders. In one embodiment the analogs are represented by the formula
• BIOTIN CONJUGATES OF ANALYTES CONTAINING AMINO, HYDROXYL, OR THIOL FUNCTIONAL GROUPS FOR USE IN IMMUNODIAGNOSTIC ASSAYS
  申请人：Calbiotech, Inc.

  公开号：US20160161473A1

  公开（公告）日：2016-06-09

  The present disclosure provides a compound having Formula I: or a pharmaceutically acceptable salt of hydrate thereof, wherein R 1 , A, m, and n are as described herein, for use in conducting immunodiagnostic assays for accurately measuring concentrations of circulating vitamin D, as well as for thyroxine and related analytes, estrogen and related analytes, and testosterone and related analytes.
• US8124596B2
  申请人：——

  公开号：US8124596B2

  公开（公告）日：2012-02-28